Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Danaher to buy Masimo in $9.9 billion deal
Danaher to buy Masimo in $9.9 billion deal
Reuters
Tue, February 17, 2026 at 10:07 PM GMT+9 1 min read
In this article:
DHR
-1.10%
AAPL
-2.27%
Feb 17 (Reuters) - Danaher will acquire pulse oximeter maker Masimo for $9.9 billion including debt, as the contract research firm looks to bulk up its diagnostics portfolio.
The companies said on Tuesday that Danaher will buy Masimo, which has been in a long legal battle with iPhone maker Apple over patents, for $180 per share. The offer represents a premium of 38.3% to Masimo’s last close.
Contract research firms have been grappling with uncertainty around drug pricing regulations in the U.S., potential tariff policies and softer academic and government research funding.
Masimo has a market capitalization of about $7 billion, while Danaher is valued at over $150 billion, according to Reuters calculations.
(Reporting by Gnaneshwar Rajan and Christy Santhosh in Bengaluru; Editing by Mrigank Dhaniwala and Shinjini Ganguli)
Terms and Privacy Policy
Privacy Dashboard
More Info